首页    期刊浏览 2024年11月08日 星期五
登录注册

文章基本信息

  • 标题:Considerations for long-term anticoagulant therapy in patients with venous thromboembolism in the novel oral anticoagulant era
  • 本地全文:下载
  • 作者:Peter P Toth
  • 期刊名称:Vascular Health and Risk Management
  • 印刷版ISSN:1176-6344
  • 电子版ISSN:1178-2048
  • 出版年度:2016
  • 卷号:12
  • 页码:23-34
  • DOI:10.2147/VHRM.S88088
  • 出版社:Dove Medical Press Ltd
  • 摘要:Background: Patients who have had a venous thromboembolic event are generally advised to receive anticoagulant treatment for 3 months or longer to prevent a recurrent episode. Current guidelines recommend initial heparin and an oral vitamin K antagonist (VKA) for long-term anticoagulation. However, because of the well-described disadvantages of VKAs, including extensive food and drug interactions and the need for regular anticoagulation monitoring, novel oral anticoagulants (NOACs) have become an attractive option in recent years. These agents are given at fixed doses and do not require routine coagulation-time monitoring. The NOACs are discussed in this review with regard to the needs of patients on long-term anticoagulation. Methods: Current guidelines from Europe and North America that refer to the treatment of deep vein thrombosis and/or pulmonary embolism are included, as well as published randomized Phase III clinical trials of NOACs. PubMed searches were used for sourcing case studies of long-term anticoagulant treatment, and results were filtered for human application and screened for relevance. Conclusion: NOAC-based therapy showed a similar efficacy and safety profile to heparins/VKAs but without the need for regular anticoagulation monitoring or dietary adjustments, and can be taken as a fixed-dose regimen once or twice daily. This represents a significant step forward in facilitating the management of long-term anticoagulation therapy. Furthermore, in the EINSTEIN studies, improved patient satisfaction was documented with the NOAC rivaroxaban, which may result in better adherence to therapy and an overall reduction in the incidence of recurrent venous thromboembolism.
  • 关键词:anticoagulation; patient needs; vitamin K antagonist; direct thrombin inhibitor; direct Factor Xa inhibitor; deep vein thrombosis; pulmonary embolism
国家哲学社会科学文献中心版权所有